Geron

After 33 years Geron could have an approved drug
After 33 years Geron could have an approved drug
EP Vantage
Geron
imetelstat
clinical trials
myelodysplastic syndromes
Flag link:
Catalysts ahead for the smaller players
Catalysts ahead for the smaller players
EP Vantage
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Flag link:
Did Geron's Big Announcement Just Go Unnoticed?
Did Geron's Big Announcement Just Go Unnoticed?
Yahoo/Motley Fool
Geron
imetelstat
myelofibrosis
Flag link:
3 Cancer Treatment Stocks on a Growth Trend
3 Cancer Treatment Stocks on a Growth Trend
Motley Fool
Geron
AbbVie
Exelixis
cancer
Flag link:
[video+transcript]How Geron's Horrible Year Is a Great Reminder to Investors
[video+transcript]How Geron's Horrible Year Is a Great Reminder to Investors
Motley Fool
Geron
JNJ
imetelstat
Flag link:
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Motley Fool
Geron
JNJ
Flag link:
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
Endpoints
JNJ
Geron
imetelstat
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Flag link:
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
Flag link:
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Yahoo/Motley Fool
JNJ
Geron
hirings
imetelstat
Imbruvica
Flag link:
2 Biotech Stocks Poised for Jaw-Dropping Growth
2 Biotech Stocks Poised for Jaw-Dropping Growth
Motley Fool
Geron
Viking Therapeutics
imetelstat
VK5211
Flag link:
A Huge Decision Is on Tap for This Little Biotech Stock
A Huge Decision Is on Tap for This Little Biotech Stock
Yahoo/Motley Fool
Geron
JNJ
imetelstat
myelofibrosis
Flag link:
3 Biotech Stocks That Skyrocketed This Week
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
Flag link:
5 Biotech Buyout Candidates for 2018
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
Flag link:
9 Notable Biotechs Presenting At This Year's ASH Meeting
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Flag link:
Geron Shares Rise on Fast Track Designation -- Biotech Movers
Geron Shares Rise on Fast Track Designation -- Biotech Movers
TheStreet.com
Geron
fast track
imetelstat
transfusion-dependent anemia
Flag link:
Geron shares plunge as J&J assesses another setback for imetelstat
Geron shares plunge as J&J assesses another setback for imetelstat
Endpoints
Geron
JNJ
imetelstat
Flag link:
Do Geron's Q2 Results Point To A Strong Close In 2016?
Do Geron's Q2 Results Point To A Strong Close In 2016?
Seeking Alpha
Geron
earnings
Flag link:
Are These 3 Biotechs Destined to Be Bought Out?
Are These 3 Biotechs Destined to Be Bought Out?
Motley Fool
Juno Therapeutics
Geron
Celator Pharmaceuticals
Flag link:

Pages